Joel Greenblatt Sarepta Therapeutics, Inc. Transaction History

Gotham Asset Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$117.53 - $155.99 $165,129 - $219,165	-1,405 Reduced 33.04%	2,847 $392,000
Q4 2022 Feb 14, 2023	SELL	$100.86 - $132.13 $969,365 - $1.27 Million	-9,611 Reduced 69.33%	4,252 $550,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $652,241 - $1.03 Million	8,615 Added 164.16%	13,863 $1.53 Million
Q2 2022 Aug 15, 2022	SELL	$62.69 - $88.44 $450,866 - $636,060	-7,192 Reduced 57.81%	5,248 $393,000
Q1 2022 May 16, 2022	BUY	$63.15 - $90.42 $785,586 - $1.12 Million	12,440 New	12,440 $972,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $131,890 - $210,755	-1,601 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$76.53 - $135.58 $122,524 - $217,063	1,601 New	1,601 $207,000
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $287,453 - $619,480	-3,948 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $7,966 - $10,788	-71 Reduced 1.77%	3,948 $600,000
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $34,027 - $48,385	-319 Reduced 7.35%	4,019 $479,000
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $838,314 - $1.28 Million	-8,614 Reduced 66.51%	4,338 $473,000
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $349,158 - $489,052	3,028 Added 30.51%	12,952 $2.09 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $711,947 - $1.53 Million	9,924 New	9,924 $1.31 Million
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $441,527 - $525,959	-9,268 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $331,145 - $436,986	9,268	9,268 $420,000

528

83.9M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.3B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Gotham Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Gotham Asset Management, LLC and Joel Greenblatt with notifications on news.